Charles Schwab’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.24M | Buy |
225,935
+18,417
| +9% | +$101K | ﹤0.01% | 2832 |
|
|
2025
Q1 | $1.31M | Buy |
207,518
+34,455
| +20% | +$217K | ﹤0.01% | 2754 |
|
|
2024
Q4 | $713K | Buy |
173,063
+22,145
| +15% | +$91.2K | ﹤0.01% | 3033 |
|
|
2024
Q3 | $504K | Hold |
150,918
| – | – | ﹤0.01% | 3162 |
|
|
2024
Q2 | $450K | Buy |
150,918
+43,211
| +40% | +$129K | ﹤0.01% | 3243 |
|
|
2024
Q1 | $372K | Hold |
107,707
| – | – | ﹤0.01% | 3129 |
|
|
2023
Q4 | $144K | Hold |
107,707
| – | – | ﹤0.01% | 3313 |
|
|
2023
Q3 | $235K | Hold |
107,707
| – | – | ﹤0.01% | 3257 |
|
|
2023
Q2 | $257K | Buy |
107,707
+95,150
| +758% | +$227K | ﹤0.01% | 3264 |
|
|
2023
Q1 | $23.2K | Hold |
12,557
| – | – | ﹤0.01% | 3487 |
|
|
2022
Q4 | $24.2K | Hold |
12,557
| – | – | ﹤0.01% | 3478 |
|
|
2022
Q3 | $20K | Hold |
12,557
| – | – | ﹤0.01% | 3477 |
|
|
2022
Q2 | $36K | Buy |
+12,557
| New | +$36K | ﹤0.01% | 3439 |
|